- Home
- IRON vs ARCB Comparison
IRON vs ARCB Comparison
Compare IRON & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- ARCB
- Stock Information
- Founded
- IRON 2017
- ARCB 1923
- Country
- IRON United States
- ARCB United States
- Employees
- IRON N/A
- ARCB N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- ARCB Trucking Freight/Courier Services
- Sector
- IRON Health Care
- ARCB Industrials
- Exchange
- IRON Nasdaq
- ARCB Nasdaq
- Market Cap
- IRON 1.4B
- ARCB 1.4B
- IPO Year
- IRON N/A
- ARCB N/A
- Fundamental
- Price
- IRON $44.24
- ARCB $61.72
- Analyst Decision
- IRON Strong Buy
- ARCB Buy
- Analyst Count
- IRON 10
- ARCB 13
- Target Price
- IRON $83.80
- ARCB $92.25
- AVG Volume (30 Days)
- IRON 397.9K
- ARCB 435.7K
- Earning Date
- IRON 05-07-2025
- ARCB 04-29-2025
- Dividend Yield
- IRON N/A
- ARCB 0.78%
- EPS Growth
- IRON N/A
- ARCB 50.16
- EPS
- IRON N/A
- ARCB 7.55
- Revenue
- IRON N/A
- ARCB $4,109,676,999.00
- Revenue This Year
- IRON N/A
- ARCB $3.83
- Revenue Next Year
- IRON N/A
- ARCB $7.17
- P/E Ratio
- IRON N/A
- ARCB $8.17
- Revenue Growth
- IRON N/A
- ARCB N/A
- 52 Week Low
- IRON $28.25
- ARCB $55.19
- 52 Week High
- IRON $68.73
- ARCB $129.83
- Technical
- Relative Strength Index (RSI)
- IRON 45.99
- ARCB 47.93
- Support Level
- IRON $40.36
- ARCB $58.16
- Resistance Level
- IRON $47.21
- ARCB $63.60
- Average True Range (ATR)
- IRON 2.87
- ARCB 3.13
- MACD
- IRON 0.10
- ARCB 0.81
- Stochastic Oscillator
- IRON 37.67
- ARCB 57.74
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About ARCB ArcBest Corporation
ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.